A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/52 (2006.01) A61K 31/517 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2566436
The invention relates generally to methods for inhibiting angiogenesis. More particularly, methods for inhibiting angiogenesis comprise selectively inhibiting phosphoinositide 3-kinase delta (P13K.delta.) activity in endothelial cells. The methods may comprise administration of one or more cytotoxic therapies including but not limited to radiation, chemotherapeutic agents, photodynamic therapies, radiofrequency ablation, anti-angiogenic agents, and combinations thereof.
L'invention concerne généralement des procédés pour inhiber l'angiogenèse. Plus particulièrement, des procédés pour inhiber l'angiogenèse comprennent sélectivement l'inhibition de l'activité de la phosphoinositide-3-kinase delta (P13K.delta.) dans les cellules endothéliales. Les procédés peuvent comprendre l'administration d'une ou plusieurs thérapies cytotoxiques, y compris entre autres l~irradiation, les agents chimiothérapiques, les thérapies photodynamiques, l~ablation par radiofréquence, les agents anti-angiogéniques, et les combinaisons de ceux-ci.
Hallahan Dennis
Hayflick Joel S.
Sadhu Chanchal
Icos Corporation
Ridout & Maybee Llp
Vanderbilt University
LandOfFree
Phosphoinositide 3-kinase delta selective inhibitors for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phosphoinositide 3-kinase delta selective inhibitors for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphoinositide 3-kinase delta selective inhibitors for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1982485